Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven W Lane

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Haematologica|April 1, 2025
Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review seriesYin Yuan, Steven W Lane
Blood|November 8, 2014
Hit the spleen, JAK!Steven W Lane, Ann Mullally
The Journal of Experimental Medicine|November 13, 2020
A knockout combination for MPN stem cellsMegan Bywater, Steven W Lane
Blood Advances|November 28, 2023
Clearing the way for new therapies in clonal hematopoiesisVictoria Y Ling, Steven W Lane
Blood Advances|October 4, 2021
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantationSiok-Keen Tey, Steven W Lane
Blood|June 3, 2017
Hacking the stem cell nicheSteven W Lane, Florian H Heidel
Seminars in Cancer Biology|December 23, 2009
Leukemia stem cellsSteven W Lane, D Gary Gilliland
Haematologica|February 1, 2023
t(15;17) in acute promyelocytc leukemiaVictoria Y Ling, Steven W Lane
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 31, 2021
Optimizing DNA hypomethylating therapy in acute myeloid leukemia and myelodysplastic syndromesJasmin Straube, Steven W Lane, Therese Vu
Blood|November 23, 2006
Increased mortality with FLA compared with ADE chemotherapy in high-risk AMLSteven W Lane, Paula Marlton, Peter N Mollee
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Haematologica|April 1, 2025
Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review seriesYin Yuan, Steven W Lane
Blood|November 8, 2014
Hit the spleen, JAK!Steven W Lane, Ann Mullally
The Journal of Experimental Medicine|November 13, 2020
A knockout combination for MPN stem cellsMegan Bywater, Steven W Lane
Blood Advances|November 28, 2023
Clearing the way for new therapies in clonal hematopoiesisVictoria Y Ling, Steven W Lane
Blood Advances|October 4, 2021
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantationSiok-Keen Tey, Steven W Lane
Blood|June 3, 2017
Hacking the stem cell nicheSteven W Lane, Florian H Heidel
Seminars in Cancer Biology|December 23, 2009
Leukemia stem cellsSteven W Lane, D Gary Gilliland
Haematologica|February 1, 2023
t(15;17) in acute promyelocytc leukemiaVictoria Y Ling, Steven W Lane
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 31, 2021
Optimizing DNA hypomethylating therapy in acute myeloid leukemia and myelodysplastic syndromesJasmin Straube, Steven W Lane, Therese Vu
Blood|November 23, 2006
Increased mortality with FLA compared with ADE chemotherapy in high-risk AMLSteven W Lane, Paula Marlton, Peter N Mollee
Pageof 11